| Literature DB >> 27072846 |
Akshay Kapoor1, Joshua M Sharfstein1.
Abstract
Despite increasing use of dietary supplements by millions of consumers, regulation of these products has not kept pace with changes and risks in the market. A major reason for this policy gridlock is the inability of different parties to come to an agreement on a path forward. The purpose of this paper is to set out a new framework for regulation in which consumers, industry, and regulators can all find common ground. This framework is based on a conceptual shift from 'benefit versus risk', the model for prescription drugs, to 'access with safety'. Steps should include registration of all dietary supplements to permit easier enforcement against rogue products, a stronger disclaimer explaining the limited role of FDA in evaluating structure/function product claims, the establishment of standard laboratory techniques for characterization of products, and more clear authority for the agency when safety concerns arise.Entities:
Keywords: FDA; dietary supplements; policy
Mesh:
Year: 2015 PMID: 27072846 DOI: 10.1002/dta.1892
Source DB: PubMed Journal: Drug Test Anal ISSN: 1942-7603 Impact factor: 3.345